(MedPage Today) -- The biomarker CK-MB should be preferred over cardiac troponin to identify coronary angioplasty-related myocardial injury that predicts later events, a new consensus statement said. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment